Jennifer Barrett, Associate Editor

Researchers have identified a potential point of intervention that could prevent the progression of liver damage to cancer.

Study identifies receptor as potential target for reversing liver damage and preventing progression to cancer.

Tocilizumab’s newest formulation offers an additional administration option for children diagnosed systemic juvenile idiopathic arthritis, a rare and debilitating disease.

Azathioprine, a drug used to treat a variety of conditions, may contribute to skin cancer development.

More than 65% of patients with Kaposi’s sarcoma in a small cohort had partial or complete remission when treated with immune checkpoint inhibitors.

B cells activate T cells in the blood to cause inflammation and brain lesions in patients with multiple sclerosis.

Azathioprine is known to cause increased photosensitivity to UVA light, but the new findings indicate an association between the drug and the mutational signature found in cases of cutaneous squamous cell carcinoma.

Early-life obesity increases the risk of several different types of cancer developing later in life.

In its multiple-ascending dose trial, ARO-HBV demonstrated reductions in circulating hepatitis B virus surface antigen.

Study identifies a potential association between azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma.

Study shows a novel treatment approach that could prevent gene changes associated with the disease.

Treatment with ibudilast reduced the progression of brain atrophy in patients with progressive multiple sclerosis compared with a placebo.

Ozanimod reduced the number of brain lesions and lowered relapse rates in patients with relapsing multiple sclerosis.

If proven effective, GLS-6150 could be the first vaccine to protect against hepatitis C virus infection.

Study provides insight into how cannabidiol acts in the brain to reduce psychotic symptoms.

Older women undergoing chemotherapy for breast cancer have a higher risk of experiencing a decline in their ability to function physically.

The effect of chemotherapy on functional status can be critical for older adults, as declining function can inhibit the ability to live independently and perform daily activities.

New report assesses the quality of rheumatic disease care across all 50 states and calls for improvements that address access to affordable care.

Patients with multiple sclerosis who smoked cigarettes had higher rates of respiratory complications and increased sedentary lifestyle.

Some older women undergoing chemotherapy for breast cancer may be more susceptible to declining physical function and inability to recover function.

Combined ipilimumab and nivolumab treatment produced durable responses in patients with melanoma brain metastases.

Supplementing a commonly used treatment approach with an additional inhibitor could help overcome resistance in glioblastoma.

Even as market disruptors such as Amazon raise concerns, pharmacies prove that the services they provide yield valuable patient experiences.

Combining pembrolizumab (Keytruda) and an investigational drug could benefit patients with advanced melanoma who have not responded to immunotherapy treatment.

The approvals of Delstrigo and Pifeltro are based on findings from 2 phase 3 clinical trials.

Medicare Part D plans will be given flexibility to tailor on-formulary drug coverage based on specific indications.

Cannabidiol treatment increased the production of inflammatory suppressor cells in mice, which reduced the clinical signs of MS.

Study highlights the importance of understanding, addressing, and bridging gaps in achieving viral suppression.

A synthetic chemical caused the self-destruction of glioblastoma tumor cells transferred from human patients into mice.

Study shows the safety and efficacy of treatment with sofosbuvir and velpatasvir in adults with recurrent chronic genotypes 1-4 HCV infection after liver transplant.